TopGum Industries, Ltd. (Israel) announced it has acquired Island Abbey Nutritionals, a leading CDMO specializing in supplement gummies and lozenges, located in Prince Edward Island, Canada. This strategic acquisition significantly expands TopGum’s manufacturing and technological capabilities, strengthening its position as a leading global provider of innovative gummy supplements, according to the company.
The acquisition serves as a cornerstone in TopGum’s strategy to drive the growth of the “Enjoyables” supplement segment. The transaction is expected to propel TopGum’s annual revenue run-rate beyond $100 million, further solidifying its position as the partner of choice to Tier-1 brands and customers worldwide.
Founded in 2004, Island Abbey has established itself as a leader in gummy and lozenge delivery formats for dietary supplements. Under the leadership of CEO Dean Williams, it recorded remarkable growth in recent years, driven by its R&D and operational excellence.
Island Abbey operates a state-of-the-art facility spanning 65,000-square-feet, in which tens of millions of dollars were invested in the last couple of years. Equipped with advanced manufacturing technologies, including starchless depositing, center-fill capabilities, and automated bottling and packaging lines, the facility adheres to stringent quality standards, such as FDA (U.S. Food and Drug Administration), NSF, GMP (good manufacturing practice), SQF (Safe Quality Food), and Health Canada certifications.
The acquisition bolsters TopGum’s strategic focus to deepen its foothold in the U.S. market. By integrating Island Abbey’s advanced capabilities, TopGum will establish an integrated supply chain with production, bottling and warehousing capabilities across two continents. The combined expertise and expanded capacity will enable TopGum to meet increasing global demand for high-quality, differentiated gummy supplements—delivering exceptional taste and reliability to its partners.
“Island Abbey brings a unique combination of strategic customers, advanced technologies, and a professional, experienced team,” said Eyal Shohat, CEO of TopGum. “Together with TopGum’s longstanding expertise, this partnership opens new horizons for innovation and growth. Our combined teams will continue to develop advanced solutions that deliver a wellness experience that is fun, easy, and tasty. We are reinforcing our commitment to our business partners and customers worldwide as we embark on this exciting new chapter in TopGum’s global growth story.”
As part of the transaction, Island Abbey will maintain its operational independence while leveraging TopGum’s global reach and resources. Island Abbey’s 95 employees will remain in place, led by Williams, a veteran of the consumer goods and nutritional supplement industries. Williams will be joining TopGum’s Executive Leadership team.
“I’m honored to be part of this pivotal moment for Island Abbey,” noted Williams. “This acquisition reflects our success in advancing supplement solutions across Canada and the US. The combination of these two entities is poised to redefine the gummy supplement market.”
For more information, visit www.topgummiceuticals.com.
